SwePub - sökning: onr:"swepub:oai:lup.lub.lu.se:...

Träfflista för sökning "onr:"swepub:oai:lup.lub.lu.se:c496ca1d-0235-41c2-a64c-f9cafb310b55" "

Sökning: onr:"swepub:oai:lup.lub.lu.se:c496ca1d-0235-41c2-a64c-f9cafb310b55"

Sortera/gruppera träfflistan

Sortering: Träffar per sida:

Numrering	Referens	Omslagsbild	Hitta
1.	Nutu, Magdalena, et al. (författare) Evaluation of the Cerebrospinal Fluid Amyloid-beta(1-42)/Amyloid-beta(1-40) Ratio Measured by Alpha-LISA to Distinguish Alzheimer's Disease from Other Dementia Disorders 2013 Ingår i: Dementia and Geriatric Cognitive Disorders. - : S. Karger AG. - 1420-8008 .- 1421-9824. ; 36:1-2, s. 99-110 Tidskriftsartikel (refereegranskat)abstract Background: The well-established core biomarkers used to identify Alzheimer's disease (AD) overlap with other dementia disorders such as dementia with Lewy bodies (DLB) and Parkinson's disease with dementia (PDD). This study aimed to evaluate whether the cerebrospinal fluid (CSF) amyloid-beta (A beta)(1-42)/A beta(1-40) ratio, measured by a novel method, could improve the differential diagnosis of AD, DLB and PDD. Method: CSF levels of A beta(1-40) and A beta(1-42) in patients with PDD, DLB, AD, Parkinson's disease and controls were analyzed using an amplified luminescent proximity homogenous immunoassay along with conventional immunoassays. Results: The CSF A beta(1-42)/A beta(1-40) ratio increased discrimination of AD from PDD and DLB compared with either of the two A beta biomarkers individually. Conclusion: The use of the A beta(1-42)/A beta(1-40) ratio could improve the differentiation of AD from PDD and DLB. (C) 2013 S. Karger AG, Basel

Skapa referenser, mejla, bekava och länka

Träfflista för sökning "onr:"swepub:oai:lup.lub.lu.se:c496ca1d-0235-41c2-a64c-f9cafb310b55" "